| Jill M Williams, MD | |
|
671 Hoes Ln, D339, Piscataway, NJ 08854-5627 | |
| (732) 235-4341 | |
| (732) 235-4277 |
| Full Name | Jill M Williams |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 31 Years |
| Location | 671 Hoes Ln, Piscataway, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366542565 | NPI | - | NPPES |
| 8575606 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0802X | Psychiatry & Neurology - Addiction Psychiatry | MA65470 (New Jersey) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA06547000 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Scleroderma Program | 5193764991 | 291 |
News Archive
In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Plasma levels of proneurotensin are associated with the development of diabetes, cardiovascular disease, cardiovascular and total mortality, and breast cancer in women during long-term follow-up, according to a study in the October 10 issue of JAMA.
The Associated Press offers a look at the major health care plans pending in Congress, including the House Democratic bill, the Senate Health, Education, Labor and Pensions Committee bill, the Baucus plan and the House Republican outline, plus President Obama's proposal.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 1 days ago
| Entity Name | Rutgers Health -rwj Psychiatric Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033207378 PECOS PAC ID: 2668464108 Enrollment ID: O20040402000376 |
News Archive
In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Plasma levels of proneurotensin are associated with the development of diabetes, cardiovascular disease, cardiovascular and total mortality, and breast cancer in women during long-term follow-up, according to a study in the October 10 issue of JAMA.
The Associated Press offers a look at the major health care plans pending in Congress, including the House Democratic bill, the Senate Health, Education, Labor and Pensions Committee bill, the Baucus plan and the House Republican outline, plus President Obama's proposal.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 1 days ago
| Entity Name | Rutgers Health-rwj Scleroderma Program |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679655781 PECOS PAC ID: 5193764991 Enrollment ID: O20050502000326 |
News Archive
In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Plasma levels of proneurotensin are associated with the development of diabetes, cardiovascular disease, cardiovascular and total mortality, and breast cancer in women during long-term follow-up, according to a study in the October 10 issue of JAMA.
The Associated Press offers a look at the major health care plans pending in Congress, including the House Democratic bill, the Senate Health, Education, Labor and Pensions Committee bill, the Baucus plan and the House Republican outline, plus President Obama's proposal.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 1 days ago
| Entity Name | Rutgers Health - Rwj Psychiatry Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316222664 PECOS PAC ID: 0042456311 Enrollment ID: O20130412000047 |
News Archive
In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Plasma levels of proneurotensin are associated with the development of diabetes, cardiovascular disease, cardiovascular and total mortality, and breast cancer in women during long-term follow-up, according to a study in the October 10 issue of JAMA.
The Associated Press offers a look at the major health care plans pending in Congress, including the House Democratic bill, the Senate Health, Education, Labor and Pensions Committee bill, the Baucus plan and the House Republican outline, plus President Obama's proposal.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill M Williams, MD 66 W Gilbert St, 2nd Floor, Tinton Falls, NJ 07701-4947 Ph: (732) 212-0051 | Jill M Williams, MD 671 Hoes Ln, D339, Piscataway, NJ 08854-5627 Ph: (732) 235-4341 |
News Archive
In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Plasma levels of proneurotensin are associated with the development of diabetes, cardiovascular disease, cardiovascular and total mortality, and breast cancer in women during long-term follow-up, according to a study in the October 10 issue of JAMA.
The Associated Press offers a look at the major health care plans pending in Congress, including the House Democratic bill, the Senate Health, Education, Labor and Pensions Committee bill, the Baucus plan and the House Republican outline, plus President Obama's proposal.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 1 days ago
Gregorio Castillo, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 671 Hoes Ln, Piscataway, NJ 08854 Phone: 800-969-5300 | |
William Reichman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln, Piscataway, NJ 08854 Phone: 800-969-5300 | |
Theodore A Petti, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln, University Behavioral Healthcare Room C-202, Piscataway, NJ 08854 Phone: 732-235-2129 Fax: 732-235-2101 | |
Peter Aupperle, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 675 Hoes Ln, Ubhc, Piscataway, NJ 08854 Phone: 732-235-4402 | |
Madhulika Sharma, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 671 Hoes Ln, Piscataway, NJ 08854 Phone: 800-969-5300 | |
Dr. Hanny S Mabrouk, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 671 Hoes Ln W Rm C-205, Piscataway, NJ 08854 Phone: 732-235-4040 | |
Stuart Belenker, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 671 Hoes Ln, Piscataway, NJ 08854 Phone: 800-969-5300 |